Biocon Ltd
NSE:BIOCON
Biocon Ltd
NSE:BIOCON
Price:
305.25 INR
-1.58%
Market Closed
Updated:
May 4, 2024
Biocon Ltd
Operating Income
|
Biocon Ltd
Operating Income Peer Comparison
Comparables:
524663
526139
Z
532039
HESTERBIO
PANACEABIO
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Biocon Ltd
NSE:BIOCON
|
Operating Income
₹18.5B
|
CAGR 3-Years
30%
|
CAGR 5-Years
18%
|
CAGR 10-Years
16%
|
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Operating Income
-₹202.8m
|
CAGR 3-Years
-119%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Transgene Biotek Ltd
BSE:526139
|
Operating Income
-₹60m
|
CAGR 3-Years
18%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Operating Income
₹123.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Operating Income
₹299.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Operating Income
-₹1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Biocon Ltd's Operating Income?
Operating Income
18.5B
INR
18.5B
INR
Based on the financial report for Dec 31, 2023, Biocon Ltd's Operating Income amounts to 18.5B INR.
What is Biocon Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
16%
16%
Over the last year, the Operating Income growth was 62%. The average annual Operating Income growth rates for Biocon Ltd have been 30% over the past three years , 18% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
